Ekso Bionics Holdings, Inc. Stock
Equities
EKSO
US2826443010
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +8.47% | +5.79% | -48.80% |
Financials (USD)
Sales 2024 * | 23.5M | Sales 2025 * | 30.5M | Capitalization | 22.92M |
---|---|---|---|---|---|
Net income 2024 * | -9M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.98 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
-2.61
x | P/E ratio 2025 * |
-5.33
x | Employees | 71 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.5% |
Latest transcript on Ekso Bionics Holdings, Inc.
1 day | +8.47% | ||
1 week | +5.79% | ||
Current month | -5.88% | ||
1 month | -11.72% | ||
3 months | -43.11% | ||
6 months | +60.00% | ||
Current year | -48.80% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 21-03-31 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 17-04-30 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 57 | 21-12-24 |
Rhonda Wallen
BRD | Director/Board Member | 57 | 20-12-28 |
Mary Cloyd
BRD | Director/Board Member | 69 | 20-12-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.28 | +8.47% | 105,061 |
24-04-24 | 1.18 | +1.72% | 25,894 |
24-04-23 | 1.16 | -9.38% | 130,377 |
24-04-22 | 1.28 | -3.03% | 132,388 |
24-04-19 | 1.32 | +9.09% | 54,021 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.80% | 22.92M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.34% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- EKSO Stock